105 related articles for article (PubMed ID: 1319810)
1. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
Wu Y; Fang D
Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):180-3. PubMed ID: 1319810
[No Abstract] [Full Text] [Related]
2. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
Longman SD; Clapham JC; Wilson C; Hamilton TC
J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
[TBL] [Abstract][Full Text] [Related]
3. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle.
Zhang H; Stockbridge N; Weir B
Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488
[No Abstract] [Full Text] [Related]
4. [Potassium agonists].
Hellwig B
Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166
[No Abstract] [Full Text] [Related]
5. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
[TBL] [Abstract][Full Text] [Related]
6. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Nakaya H
Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
[No Abstract] [Full Text] [Related]
7. Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential.
Longman SD; Hamilton TC
Med Res Rev; 1992 Mar; 12(2):73-148. PubMed ID: 1535674
[No Abstract] [Full Text] [Related]
8. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
9. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
Yanagisawa T; Hashimoto H; Taira N
Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery.
Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vasodilatation by the K+ channel openers: cromakalim and pinacidil.
Rhim BY; Lee WS; Hong KW
Jpn J Pharmacol; 1992; 58 Suppl 2():335P. PubMed ID: 1507584
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function.
Plant TD; Garrino MG; Henquin JC
Pflugers Arch; 1989; 414 Suppl 1():S152-3. PubMed ID: 2528721
[No Abstract] [Full Text] [Related]
13. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
Triggle CR; Li YQ; Wyse DG
Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
[No Abstract] [Full Text] [Related]
14. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim.
Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D
Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469
[TBL] [Abstract][Full Text] [Related]
15. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm.
Zhang H; Cook D
Pharmacol Toxicol; 1994 Dec; 75(6):327-36. PubMed ID: 7899253
[TBL] [Abstract][Full Text] [Related]
16. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
17. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
Satoh K
Nihon Rinsho; 1993 May; 51(5):1293-8. PubMed ID: 8331797
[TBL] [Abstract][Full Text] [Related]
18. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
[TBL] [Abstract][Full Text] [Related]
19. Essential role of nucleotide diphosphates in nicorandil-mediated activation of cardiac ATP-sensitive K+ channel. A comparison with pinacidil and lemakalim.
Shen WK; Tung RT; Machulda MM; Kurachi Y
Circ Res; 1991 Oct; 69(4):1152-8. PubMed ID: 1834361
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
Weston AH
Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
